Visual Field Changes and OCT Angiographic Chorioretinal Changes in Patients With Primary Open Angle Glaucoma
NCT ID: NCT06978101
Last Updated: 2025-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2021-12-30
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anterior Segment Changes by Optical Coherence Tomography (OCT) in Phaco- Trabeculectomy
NCT03626675
Comparison of Optical Coherence Tomography Angiography Microvascular Changes in Primary Open Angle and Primary Angle Closure Glaucoma
NCT06000176
OCTA in Patients With Primary Open-angle Glaucoma
NCT06214676
Correlation Between Optical Coherence Tomography Angiography and Photopic Negative Response in Patients With Glaucoma
NCT05104294
AS-OCT Evaluation of Iridocorneal Angle of Patients of Angle Closure Glaucoma After Phacoemulsification
NCT05332665
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Currently, there are 2 groups of complementary exams used for the diagnosis and follow-up of glaucoma patients: structural (where OCT has a considerable role) and functional (visual field) optic nerve measurements, Both technologies have strengths and limitations.
A new technology for diagnosis and follow-up that can avoid the limitations summarized above is lacking. OCTA seems to be a good candidate for such a role, OCT can detect the Doppler frequency shift of the backscattered light that provides information on blood flow.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
POAG group
Patients had intraocular pressure (IOP)\>21 mmHg,
POAG group
Patients had intraocular pressure (IOP)\>21 mmHg.
Control group
Patients without family history of primary open-angle glaucoma (POAG), IOP ˂21mm Hg.
Control group
Patients without family history of primary open-angle glaucoma (POAG), IOP ˂21mm Hg.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
POAG group
Patients had intraocular pressure (IOP)\>21 mmHg.
Control group
Patients without family history of primary open-angle glaucoma (POAG), IOP ˂21mm Hg.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Diabetic Retinopathy.
3. Uveitis.
4. Other Glaucomas
* Acute congestive glaucoma
* Secondary glaucomas
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Miadaa Hassan Hassaneen
Assistant Lecturer of Ophthalmology Department, Al-Azhar Faculty of Medicine in Assiut.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MD/AZ.AST./OPH026/10/191/1/202
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.